Anna Protopapas, M.B.A.

Anna Protopapas, M.B.A.

Chief Executive Officer and Board Member

EDUCATION
B.S., Science and Engineering, Princeton University
M.S., Chemical Engineering Practice, Massachusetts Institute of Technology
M.B.A., Stanford Graduate School of Business

PREVIOUS EXPERIENCE
Mersana Therapeutics
Takeda Pharmaceutical Company
Millennium Pharmaceuticals

Anna’s FlareTx Characteristics: Proven leader in building biotech businesses and collaborating with exceptional teams to deliver meaningful medicines to patients.

Anna has almost three decades of experience building and scaling biotech companies. She has a proven track record of advancing complex drug development platforms, raising significant capital, and driving organizational growth and transformation, including guiding companies through IPOs, major partnerships and acquisitions. Her operational experience spans oncology drug discovery and large-scale global business development, having led more than $20 billion in transactions over the course of her career.

She is also a seasoned board leader with experience across multiple stages of company growth, having supported management teams through pipeline advancement, equity financings and value-creating exits totaling more than $30 billion.

In her free time, Anna enjoys spending time with her family. She was born and grew up in Cyprus, a place she visits regularly to bask in the mediterranean sun.

WHAT MAKES YOU EXCITED TO ‘BRING IT’ EVERY DAY AT WORK?

…Because patients are waiting!

WHAT SPARKED YOU TO JOIN FLARETX?

Great science, great pipeline, great team and an incredible potential to make a difference in prostate cancer patients!

 

This links to an external website.

Continue